One hundred and ten cases of sarcoidosis seen in Cape Town over a 7-year period (1969-1975) are reported. Seventy-one patients were Coloured, 25 Black and 14 White. The calculated minimum incidence of sarcoidosis in the Cape Peninsula is 23,2/100 000 population in Blacks, 11,6/100 000 in Coloureds and 3,7/100 000 in Whites. Differences in the incidence, presentation, clinical and laboratory features in the three groups of patients are presented and discussed. The differences between Whites and Blacks are similar to those reported from the USA, and the Coloured patients resemble the Blacks. The study clarifies some of the misconceptions about the incidence of sarcoidosis in South Africa, and documents the similarity of sarcoidosis in American and African Blacks.
Download full-text PDF |
Source |
---|
Diabetes Metab Syndr
January 2025
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. Electronic address:
Objective: To investigate the causal association of using glucagon-like peptide-1 receptor (GLP1R) agonists with autoimmune diseases.
Methods: The available cis-eQTLs for drugs target genes (GLP1R) were used as genetic variants for exposure to GLP1R agonists. Type 2 diabetes was used as positive control.
PLoS One
January 2025
Department of Internal Medicine, Seth GS Medical College and KEM Hospital, Mumbai, India.
Introduction: Sarcoidosis is an inflammatory disease characterized by granulomas, the etiology of which remains unclear. This study examines sarcoidosis-related mortality trends in the United States from 1999 to 2020, with a focus on disparities pertaining to patient sex, geographical location, and urbanization status.
Methods: We analyzed death certificate data from the CDC WONDER database, using ICD-10 code D86.
Circ Arrhythm Electrophysiol
January 2025
Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Finland (P.P., J.L., D.V., H.M., P.S., H.-K.N., M.K.).
Background: Cardiac sarcoidosis involves a significant but difficult-to-define risk of sudden cardiac death (SCD). Current guidelines recommend consideration of an implantable cardioverter defibrillator for patients with extensive or significant myocardial late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging. However, extensive/significant LGE is not defined.
View Article and Find Full Text PDFJACC Case Rep
December 2024
Department of Cardiology, St Vincent's Hospital Sydney, Darlinghurst, Sydney, New South Wales, Australia.
We report a unique case involving cardiac manifestation of T-cell lymphoma and associated risk management of ventricular arrhythmia and sudden cardiac death. A 39-year-old woman presented with a syndrome consistent with fever in a returned traveler, ultimately diagnosed with stage IV peripheral T-cell lymphoma involving the myocardium with ventricular tachycardia. Management of risk of sudden cardiac death was complicated by hematological management with an antibody-drug conjugate chemotherapy regimen and later autologous stem cell transplant.
View Article and Find Full Text PDFOphthalmic Plast Reconstr Surg
December 2024
Orbital, Plastics and Lacrimal Unit, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!